Antonia Le Gruyer

Antonia Le Gruyer

UNVERIFIED PROFILE

Are you Antonia Le Gruyer?   Register this Author

Register author
Antonia Le Gruyer

Antonia Le Gruyer

Publications by authors named "Antonia Le Gruyer"

Are you Antonia Le Gruyer?   Register this Author

4Publications

513Reads

11Profile Views

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.

N Engl J Med 2018 Jun;378(23):2171-2181

From the Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis, Hepatology and Gastroenterology Department, Saint-Antoine University Hospital, Assistance Publique-Hôpitaux de Paris (APHP) (C.C., O.C., S.L., F.G., R.P.), INSERM Unité Mixte de Recherche (UMR) S938 (C.C., O.C., S.L., R.P.) and the Biochemistry Laboratory (L.H., D.R.), Saint-Antoine University Hospital, APHP, INSERM Unité 1157/UMR 7203, Sorbonne University, the Biochemistry Laboratory, Tenon University Hospital, APHP (G.L.), and the Immunology Laboratory, INSERM UMR S996, Bichat University Hospital, APHP (L.C., S.C.-M.), Paris-Sud University, the Department of Clinical Pharmacology and Clinical Research Platform of the East of Paris, APHP (A.R., F.-H.A., T.S.), and Sorbonne University (T.S.), Paris, the Hepatology and Gastroenterology Department, Rouen University Hospital, Rouen (O.G.), the Hepatology and Gastroenterology Department, Pontchaillou University Hospital, Rennes (A.L.G.), the Hepatology and Gastroenterology Department, University Hospitals of Strasbourg, Institute of Viral and Liver Diseases, INSERM Unité 1110, Laboratory of Excellence HepSYS, University of Strasbourg, Strasbourg (F.H.), the Hepatology and Gastroenterology Department, Claude Huriez University Hospital, Lille (P.M.), the Hepatology and Gastroenterology Department, Orleans Hospital, Orleans (P.P.), the Hepatology and Gastroenterology Department, Dijon Bourgogne University Hospital, Dijon (A.M.), the Hepatology and Gastroenterology Department, University Hospital of Poitiers, Poitiers (C.S.), the Hepatology and Gastroenterology Department, Estaing University Hospital, Clermont-Ferrand (A.A.), the Hepatology and Gastroenterology Department, University Hospital of Limoges, Limoges (M.D.-G.), the Hepatology and Gastroenterology Department, Saint-Eloi University Hospital, Montpellier (D.L.), the Hepatology Department, Beaujon University Hospital, Clichy (O.R.), the Hepatology and Gastroenterology Department, Brabois University Hospital, Nancy (J.-P.B.), the Hepatology and Gastroenterology Department, University Hospital of Angers, Hemodynamics, Interaction, Fibrosis, and Tumor Invasiveness in Hepatic and Digestive Organs Laboratory, Unité Propre de Recherche de l'Enseignement Supérieur 3859, Structures Fédératives de Recherche 4208, Bretagne Loire University, Angers (J.B.), the Hepatology and Gastroenterology Department, Haut-Lévêque University Hospital, Pessac (V.L.), the Hepatology and Gastroenterology Department, Robert Debré University Hospital, Reims (A.H.-B.), the Hepatology and Gastroenterology Department, University Hospital of Amiens, Amiens (E.N.-K.), the Hepatology and Gastroenterology Department, Croix-Rousse University Hospital, Lyon (F.Z.), the Hepatology and Gastroenterology Department, University Hospital of Caen, Caen (I.O.-H.), the Hepatology and Gastroenterology Department, Michallon University Hospital, Grenoble (J.-P.Z.), and the Hepatology and Gastroenterology Department, Jean Verdier University Hospital, Bondy (G.N.) - all in France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1714519DOI Listing
June 2018

Acoustic radiation force impulse imaging for assessing liver fibrosis in alcoholic liver disease.

World J Gastroenterol 2016 May;22(20):4926-35

Anita Kiani, Vanessa Brun, Yves Gandon, Department of Abdominal Imaging, Rennes University Hospital, 35033 Rennes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v22.i20.4926DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873885PMC
May 2016

Chronic hepatitis C: treat or wait? A prospective study on reasons for treatment or nontreatment in the era of first-generation protease inhibitors.

Eur J Gastroenterol Hepatol 2016 Feb;28(2):164-72

aDepartment of Hepato-Gastroenterology bDepartment of Internal Medicine, University Hospital of Brest La Cavale Blanche, Brest cHepatology Department, Pontchaillou University Hospital, Rennes dDepartment of Hepatology and Gastroenterology, Laennec Hospital-GHPSO, Creil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0000000000000506DOI Listing
February 2016